Table 1 . Correlation between PG I, PG II, gastrin and Cag A serum levels with demographic and lifestyle: characteristics (n=846).
|
Characteristics |
Categories |
N(%) |
PG I
(30-165 µg/l) |
p |
PG II
(3-15 µg/l) |
p |
Gastrin
(1-10 p mol/l) |
p |
Cag A
(0-30 EIU) |
p |
| Gender | Male | 305 (36.1) | 116.6±57.1 | 0.001 | 17.8±11.1 | .322 | 6±4.5 | .573 | 30.5±37 | 0.001 |
| Female | 541 (63.9) | 103.1±55.8 | 17±11.7 | 5.8±4 | 37.7±41.7 | |||||
| Age (years) | 29-44 | 302 (35.7) | 118±60.8 | 0.01 | 18.6±12.1 | 5.9±4.8 | 0.133 | 27.4±35 | 0.007 | |
| 45-54 | 268 (31.7) | 112.7±59.3 | 19.4±12.2 | 5.4±2.2 | 32.6±39.6 | |||||
| 55-64 | 155 (18.3) | 108±57 | 18±11.7 | 6.3±4.6 | 37.9±41 | |||||
| >65 | 121 (14.3) | 100.8±52.3 | 14.9±10.2 | 6.2±5.3 | 36.3±41 | |||||
| BMI | Thin | 10 (1.2) | 103.5±52.3 | 0.2 | 18±7.6 | 0.05 | 5.8±3.5 | 0.8 | 37.2±39.1 | 0.8 |
| Normal | 266 (31.5) | 112.8±61 | 18.8±12.7 | 5.8±4.2 | 34±40.3 | |||||
| Overweight | 381 (45) | 107.5±55.1 | 16.6±10.8 | 6±4.5 | 35.9±40.1 | |||||
| Obese | 189 (22.3) | 102.5±53.1 | 16.2±11 | 5.6±3.6 | 35.4±40.5 | |||||
| Smoking | Negative | 656(77.5) | 106.9±56.2 | 0.3 | 17.1±11.4 | 0.48 | 5.9±4.2 | 0.6 | 37±41.2 | 0.001 |
| Positive | 190 (22.5) | 111.6±58 | 17.8±11.5 | 5.7±4.2 | 29.3±36.4 | |||||
| Residence | Urban | 618 (73) | 110.3±55.7 | 0.02 | 17.3±11.6 | 0.9 | 5.8±4.2 | 0.9 | 34.6±40.2 | 0.4 |
| Rural | 228 (27) | 100.2±58.1 | 17.2±11.2 | 5.8±4.4 | 36.2±40.4 | |||||
| NSAID use | Negative | 617 (72.9) | 108.9±57.1 | 0.4 | 17.4±12.1 | 0.4 | 5.9±4.2 | 0.6 | 34.4±40.1 | 0.2 |
| Positive | 229 (27.1) | 105.5±55.2 | 16.8±9.7 | 5.7±4.3 | 37±40.5 | |||||
| Activity | Negative | 495 (58.5) | 106.3±57.7 | 0.3 | 17.8±11.9 | 0.08 | 6±4.5 | 0.2 | 34.8±39.8 | 0.7 |
| Positive | 351 (41.5) | 110.3±54.9 | 16.4±10.8 | 5.6±3.7 | 35.6±40.9 | |||||